STOCK TITAN

Multiple resale transactions by affiliate reported for Phibro Animal Health (PAHC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Phibro Animal Health Corporation submitted a Form 144 notice indicating proposed sales of Class A Common Stock by an affiliate, with multiple transactions listed through February 2026. The excerpt includes numerous brokered sell entries by BFI Co. LLC, including large single-day totals such as 58,042 shares and 49,280 shares.

The filing lists transaction dates and per‑trade share counts and proceeds; the excerpt does not state aggregate registered offering treatment or who receives proceeds.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists multiple proposed resale transactions by an affiliate; sequencing and broker details are recorded.

The notice catalogs numerous proposed brokered sales of Class A Common Stock by BFI Co. LLC, showing per‑trade share counts and gross proceeds for trades dated January–February 2026. This is a routine resale disclosure required when an affiliate intends to sell restricted or control securities through brokers.

Cash‑flow treatment and any aggregate registration amount are not stated in the excerpt; subsequent filings or broker confirmations would show settlement details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Phibro Animal Health Corporation's Form 144 disclose?

The Form 144 discloses proposed resale transactions of Class A Common Stock by an affiliate. It lists multiple trade dates, individual share counts, and gross proceeds amounts for brokered sales in January–February 2026.

Who is the selling party in the Form 144 entries for PAHC?

The excerpt lists BFI Co. LLC as the selling affiliate. The table shows many individual trades attributed to that entity with per‑trade share counts and dollar proceeds recorded.

Does the Form 144 state the total number of shares registered for resale?

The provided excerpt does not present a single aggregate registered amount. The content shows multiple per‑trade quantities; an aggregate registered figure is not stated in the excerpt.

Are proceeds recipients or use of proceeds specified in this Form 144 excerpt?

No. The excerpt records gross proceeds per trade but does not state who receives proceeds or how proceeds will be used. Cash‑flow treatment is not described in the provided text.

What dates do the listed proposed sales cover in the excerpt?

The entries shown cover trade dates in January and February 2026, with multiple executions recorded on specific dates such as 02/05/2026 and 02/10/2026.
Phibro Animal

NASDAQ:PAHC

View PAHC Stock Overview

PAHC Rankings

PAHC Latest News

PAHC Latest SEC Filings

PAHC Stock Data

2.07B
20.46M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TEANECK